Peking University People’s Hospital Rheumatology: The Short Answer

Peking University People’s Hospital runs a rheumatology and immunology department that handles a high volume of complex autoimmune cases — rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome, ankylosing spondylitis, vasculitis, and more. For a foreign patient, the realistic path is through the hospital’s international medical services or VIP outpatient channel, which allows advance scheduling rather than same-day queueing. That access comes at a premium: expect to pay roughly 1.5 to 2 times the standard outpatient rate.

But here is the caveat that complicates a simple yes-or-no answer. The department’s public outpatient clinics do not accept advance bookings from overseas. You cannot email the hospital, reserve a slot for next Tuesday, and show up. Standard registration happens on the day of the visit, in person, often through a mobile app that requires a Chinese phone number and ID. For most international patients, the practical route is either a hospital-facilitated international appointment or a coordination service that handles registration on your behalf.

Is Peking University People’s Hospital good for lupus treatment? Based on its clinical volume, research output, and standing in national rheumatology rankings, yes — it is widely considered one of the strongest centers in northern China for lupus and related connective tissue diseases. But “good” depends on what you need: a one-time second opinion, a comprehensive treatment plan, or ongoing biologic therapy management.

Who This Is Right For — and Who It Isn’t

Some patients benefit enormously from coming to Beijing for rheumatology care. Others would be better served staying home or choosing a different model entirely. Here is the honest breakdown.

Typically a good candidate:

• You have a confirmed or suspected autoimmune diagnosis and want a second opinion from a high-volume Chinese rheumatology team
• Your condition is stable enough to travel, but you want to explore treatment options — including biologics, JAK inhibitors, or combination DMARDs — at a lower cost than in the US or Europe
• You already live in Asia or travel to China regularly, making follow-up visits feasible
• You have complex, treatment-resistant disease and are willing to invest time in a thorough evaluation
• You need written documentation or a video consultation before committing to travel — both of which this department can support through its international channel

Not a good candidate:

• You are in an active disease flare requiring urgent hospitalization — coordinating emergency rheumatology admission from abroad is difficult and often not faster than local care
• You cannot commit to at least one in-person visit; remote consultation has limits for conditions that require physical joint examination and imaging
• Your primary concern is cost alone and you have not compared the full expense: flights, accommodation, visa, and coordination fees add up
• You need ongoing biologic infusions every 4–8 weeks and cannot realistically return to Beijing that often
• You expect a single visit to produce a definitive cure — autoimmune diseases require long-term management, not one-time fixes

The Options, Compared

If you are considering rheumatology care in Beijing, you are really choosing between four distinct service models. Each has different implications for cost, speed, and the depth of evaluation you receive.

The standard public clinic is the cheapest but effectively inaccessible to most foreign patients without local help. The international channel is the realistic in-person option. Written second opinions and video consultations are the smart first step for anyone unsure whether travel is justified — and both can be credited toward on-the-ground coordination if you later decide to come.

Rheumatoid Arthritis Treatment Cost in China: What Actually Drives the Price

Rheumatoid arthritis treatment cost in China varies enormously depending on which medications you need. Conventional DMARDs like methotrexate and leflunomide are inexpensive — often under $20 per month. Biologics are a different story. Adalimumab (Humira) biosimilars in China now run roughly $200–400 per month, compared to $2,000–5,000 per month in the US for the originator. Tocilizumab and rituximab biosimilars follow similar patterns. JAK inhibitors like tofacitinib sit in between.

What does not show up in the drug price is the diagnostic workup. A thorough rheumatology evaluation at Peking University People’s Hospital typically includes autoimmune antibody panels, inflammatory markers, joint ultrasound or MRI, and sometimes a minor salivary gland biopsy for Sjögren’s assessment. That workup can add $300–800 depending on scope. None of this is inflated for foreigners at the public hospital level — but the international channel adds a service premium for scheduling, English coordination, and reduced waiting.

How to Make an Appointment at Peking University People’s Hospital Rheumatology from Abroad

The question we hear most often: how to make an appointment Peking University People’s Hospital rheumatology from abroad? The honest answer is that you cannot do it directly through the public registration system. But you have two viable routes.

Route one: contact the hospital’s international medical services department directly. They can schedule outpatient visits through the VIP or international clinic, usually with a few days to two weeks of lead time. You will need your passport, a summary of your medical history, and ideally translated records. The hospital may request a deposit or prepayment for the consultation.

Route two: use a coordination service like ours. We handle registration, creation of the hospital medical card, record translation, and in-person proxy visits if needed. The international patient coordinator at Peking University People’s Hospital — whether hospital-employed or third-party — is the person who makes the system work for you. Without one, you are navigating a Chinese-language registration app and a hospital campus that sees over 10,000 outpatient visits daily.

Neither route guarantees you a specific named specialist on a specific date. What both routes do is move you from “impossible to book from abroad” to “scheduled and supported.” That is the real value.

Practical Considerations: Records, Visa, Payment, and Follow-Up

Before you book anything, sort out the logistics. They matter as much as the medical decision.

Medical records. Bring everything: previous rheumatology notes, lab results, imaging reports, and a medication list with dosages. Translate key documents into Chinese or English. If records are in another language, budget for professional translation — the hospital will not interpret handwritten notes from a clinic in another country.

Visa. Medical treatment in China falls under the S2 visa category for short stays, with S1 for stays exceeding 180 days. Accompanying family members also apply for S2. The hospital or coordination service can provide an invitation letter and supporting documents, but approval is never guaranteed and processing times vary by consulate.

Payment. Public hospitals in China require prepayment — you load funds onto a hospital card and services are deducted as you go. International channels may accept credit cards or bank transfer. Insurance is typically reimbursement-based: you pay upfront, then claim from your insurer. Private international hospitals in Beijing offer direct billing, but Peking University People’s Hospital is a public institution and generally does not.

Follow-up after returning home. This is the part most patients underestimate. If the rheumatology team prescribes a biologic, you need a plan for continuing it at home. Some medications available in China are not yet approved in other countries, and vice versa. Ask explicitly: “What do I do with this treatment plan when I am back in my home country?” The answer should shape your decision to travel in the first place.

Frequently Asked Questions